# A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets

> **NCT03437564** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 28 (actual)

## Conditions studied

- Healthy Adult Participants

## Interventions

- **DRUG:** Vortioxetine

## Key facts

- **NCT ID:** NCT03437564
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-16
- **Primary completion:** 2018-04-13
- **Final completion:** 2018-04-13
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2019-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03437564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03437564, "A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03437564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*